- Home
- CHRO vs BFRI Comparison
CHRO vs BFRI Comparison
Compare CHRO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- BFRI
- Stock Information
- Founded
- CHRO 2002
- BFRI 1997
- Country
- CHRO United States
- BFRI United States
- Employees
- CHRO N/A
- BFRI N/A
- Industry
- CHRO
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- CHRO
- BFRI Health Care
- Exchange
- CHRO Nasdaq
- BFRI Nasdaq
- Market Cap
- CHRO 7.6M
- BFRI 7.5M
- IPO Year
- CHRO 2024
- BFRI 2021
- Fundamental
- Price
- CHRO $1.35
- BFRI $0.62
- Analyst Decision
- CHRO
- BFRI Strong Buy
- Analyst Count
- CHRO 0
- BFRI 1
- Target Price
- CHRO N/A
- BFRI $2.75
- AVG Volume (30 Days)
- CHRO 135.3K
- BFRI 188.7K
- Earning Date
- CHRO 08-12-2025
- BFRI 08-13-2025
- Dividend Yield
- CHRO N/A
- BFRI N/A
- EPS Growth
- CHRO N/A
- BFRI N/A
- EPS
- CHRO N/A
- BFRI N/A
- Revenue
- CHRO N/A
- BFRI $37,997,000.00
- Revenue This Year
- CHRO N/A
- BFRI $11.75
- Revenue Next Year
- CHRO N/A
- BFRI $17.09
- P/E Ratio
- CHRO N/A
- BFRI N/A
- Revenue Growth
- CHRO N/A
- BFRI 14.28
- 52 Week Low
- CHRO $0.45
- BFRI $0.54
- 52 Week High
- CHRO $3.80
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- CHRO 63.60
- BFRI 45.79
- Support Level
- CHRO $1.12
- BFRI $0.61
- Resistance Level
- CHRO $1.23
- BFRI $0.66
- Average True Range (ATR)
- CHRO 0.16
- BFRI 0.05
- MACD
- CHRO 0.01
- BFRI 0.00
- Stochastic Oscillator
- CHRO 30.26
- BFRI 35.00
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.